Structured Summary
Abstract
The detection of genetic variability (e.g., PHARMACOGENOMIC VARIANTS) relevant to PHARMACOGENETICS and PRECISION MEDICINE. The purpose of such genetic testing is to help determine the most effective treatment options and their optimum dosages with least potential risks for DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS.
MeSH Record
Classification
Broader headings
Related Concepts
Knowledge Graph
Loading graph…
Drag nodes to rearrange; hover to trace links; click a node to open its page.
MeSH Record
Synonyms
16 entry terms
- Pharmacogenetic Screening
- Pharmacogenetic Testing
- Pharmacogenomic Screening
- Pharmacogenetic Screenings
- Pharmacogenetic Testings
- Pharmacogenomic Screenings
- Pharmacogenomic Testings
- Pharmacogenetic Analysis
- Pharmacogenetic Study
- Pharmacogenomic Analysis
- Pharmacogenomic Study
- Pharmacogenetic Analyses
- Pharmacogenetic Studies
- Pharmacogenomic Analyses
- Pharmacogenomic Studies
- Studies, Pharmacogenetic
MeSH Record
Aspects Covered
11 allowable subheadings
Indexed with the subheadings classification, economics, ethics, history, instrumentation, legislation & jurisprudence, methods, standards, statistics & numerical data, trends, veterinary.
MeSH Record
History Note
2017
MeSH Record
Previous Indexing
- Genetic Testing (2001-2016)
- Pharmacogenetics (2001-2016)
MeSH Hierarchy
Tree Numbers
AMA Style
References
- National Library of Medicine. Pharmacogenomic Testing. Medical Subject Headings (MeSH). 2026. Unique ID D000071185. http://id.nlm.nih.gov/mesh/2026/D000071185
- Pharmacogenomic Testing. In: Wikidata. https://www.wikidata.org/wiki/Q70348257